Abstract
We evaluated magnetic resonance imaging (MRI) changes in ankylosing spondylitis (AS) patients with longstanding disease and investigated whether there is any relationship between MRI findings and validated methods of disease assessment. A total of 34 AS patients with disease duration greater than 10 years were included in this observational cross-sectional study (26 men, 8 women). The main outcome measures were Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Global assessment (BASG), Bath Ankylosing Spondylitis Metrology Index (BASMI), MRI of the thoracic and lumbar spine (AS spi MRI A) and measurement of serum erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), plasma viscosity (PV) and immunoglobulin A (Ig A). The median scores for the acute lesions based on AS spi MRI A scoring system was 2.5 (0–4.12). The respective mean ESR and CRP were 36 (SD, 24.00) mm/h and 14.19 (SD, 24.00) mg/l with the median PV of 1.8 (1.75–1.87). The median BASG, BASFI and BASDAI were 4.55 (2.37–5.55), 4.40(2.31–5.47) and 4.32 (3.07–6.48), respectively. No significant correlations were found between the acute MRI scores and each of the clinical instruments and laboratory markers of inflammation. In this study, majority of AS patients with longstanding disease had very low AS spi MRI A scores or no evidence of spinal inflammatory lesions. Our study would suggest that MRI should be used along with other measures of disease activity in the assessment of symptomatic AS patients with longstanding disease.
Similar content being viewed by others
References
Brophy S, Mackay K, Al Saidi A, Taylor G, Calin A (2002) The natural history of Ankylosing Spondylitis as defined by radiological progression. J Rheumatol 29(6):1236–1243
Dawes PT (1999) Stoke AS spine score. J Rheumatol 26:993–996
Kennedy LG, Edmunds L, Calin A (1993) The natural history of AS. Does it burn out. J Rheumatol 20(4):688–692
Gran JT, Skomsvoll JF (1997) The outcome of ankylosing spondylitis; a study of 100 patients. Br J Rheumatol 36(7):766–771
Taylor AL, Balakrishnan C, Calin A (1998) Reference centile charts for measures of disease activity, functional impairment and metrology in ankylosing spondylitis. Arthritis Rheum 41(6):1119–1125
Maksymowych WP, Jauregui E, Spady B, Russell AS (2003) The BATH Ankylosing Spondylitis Disease Activity index: lack of discriminant ability between AS and mechanical low back pain [abstract]. EULAR 2003 meeting Lisbon, Portugal
de Vlam K, Bokken A (2005) BASDAI is unable to discriminate between inflammatory low back pain and mechanical low back pain. Ann Rheum Dis 64(suppl 3):335
Barkham N, Kong KO, Tennant A, Fraser A, Hensor E, Keenan AM et al (2005) The unmet need for anti- tumour necrosis factor (anti- TNF) therapy in ankylosing spondylitis. Rheumatology 44(10):1277–1281
Kenny JB, Hughes PL, Whitehouse GH (1990) Discovertebral destruction in ankylosing spondylitis: the role of computed tomography and magnetic resonance imaging. Br J Radiol 63(750):448–455
Jevtic V, Kos-Golja M, Rozman B, McCall I (2000) Marginal erosive discovertebral “Romanus” lesions in ankylosing spondylitis demonstrated by contrast enhanced Gd-DTPA magnetic resonance imaging. Skelet Radiol 29(1):27–33
Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J et al (2003) Magnetic Resonance Imaging Examination of the spine in patients with AS, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 48(4):1126–1136
Braun J, Baraliakos X, Golder W, Hermann KG, Listing J, Brandt J et al (2004) Analysing chronic spinal changes in AS: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 63(9):1046–1055
Braun J, Bollow M, Eggens U, Konig H, Distler A, Sieper J (1994) Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroilitis in spondyloarthropathy patients. Arthritis Rheum 37(7):1039–1045
Baraliakos X, Landewe R, Hermann KG, Listing J, Golder W, Brandt J et al (2005) Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging. Ann Rheum Dis 64(5):730–734
Marc V, Dromer C, Le Guennec P, Manelfe C, Fournie B (1997) Magnetic resonance imaging and axial involvement in spondyloarthropathies. Rev Rhum Engl Ed 64(7–9):465–473
Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J et al (2000) Successful treatment of active ankylosing spondylitis with anti-tumour necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 43(6):1346–1352
Maksymowych WP, Landewe R (2006) Imaging in ankylosing spondylitis. Best Pract Res Clin Rheumatol 20(3):507–519
Rigby AS, Silman AJ (1991) Outcome assessment in clinical trials of ankylosing spondylitis. Br J Rheumatol 30(5):321–322
Spoorenberg A, Van Tubergen A, Landewe R, Dougados M, van der Linder S, Mielants H et al (2005) Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology 44(6):789–795
Taylor HG, Wardle T, Beswick EJ, Dawes PT (1991) The relationship of clinical and laboratory measurements to radiological change in Ankylosing Spondylitis. Br J Rheumatol 30(5):330–335
van der Heijde DM, Van’t Hof M, van Riel PL, van de Putte LB (1993) Validity of single variables and indices to measure disease activity in Rheumatoid arthritis. J Rheumatol 20(3):538–541
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368
Van der Heijde D, Landewe R, Hermann KG, Rudwaleit M, Ostergaard M, Oostveen A et al (2007) Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis. J Rheumatol 34(4):871–873
Rennie WJ, Dhillon SS, Conner-Spady B, Maksymowych WP, Lambert RGW (2006) Standard MRI assessment of spinal inflammatory lesions in AS may omit a significant component of inflammation in the thoracic spine. Ann Rheum Dis 65(suppl 2):534
Muche B, Bollow M, Francois RJ, Sieper J, Hamm B, Braun J (2003) Anatomic structures involved in early and late-stage sacroilitis in spondyloarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum 48(5):1374–1384
Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreimann M, Hempfing A et al (2006) Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 8(5):R143
Sheehan NJ, Slavin BM, Donovan MP, Mount JN, Mathews JA (1986) Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in Ankylosing Spondylitis. Br J Rheumatol 25(2):171–174
Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E et al (1999) Clinical relevance of CRP in axial involvement of Ankylosing Spondylitis. J Rheumatol 26(4):971–974
Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26(4):966–970
Baraliakos X, Davis J, Tsuji W, Braun J (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein Etanercept. Arthritis Rheum 52(4):1216–1223
Sieper J, Baraliakos X, Listing J, Brandt J, Haibel H, Rudwaleit M et al (2005) Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondyltis after two years of treatment with the anti- tumour necrosis factor agent infliximab. Rheumatology 44(12):1525–1530
Baraliakos X, Brandt J, Listing J, Haibel H, Sorensen H, Rudwaleit M et al (2005) Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. Arthrits Rheum 53(6):856–863
Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden S, Brandt J (2002) Conventional treatment for ankylosing spondylitis. Ann Rheum Dis 61(suppl 3):40–50
34 The British Society for Rheumatology (2004) BSR Guidelines for prescribing TNF alpha blockers in adults with ankylosing spondylitis. http://www.rheumatology.org.uk
Marzo-ortega H, McGonagle D, Jarrett S, Haugeberg G, Hensor E, O’connor P et al (2005) Infliximab in combination with methotrexate in active Ankylosing Spondylitis: A clinical and imaging study. Ann Rheum Dis 64(11):1168–1175
Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J (2004) Prediction of a major response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 63(6):665–670
Lukas C, Braun J, van der Heijde D, Hermann KG, Rudwaleit M, Ostergaard M (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol 34(4):862–870
Baraliakos X, Hermann KGA, Landewe R, Listing J, Golder W, Brandt J et al (2005) Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis 64(8):1141–1144
Acknowledgements
We are grateful to Dr. MJ Davis and Prof. A D Woolf (Royal Cornwall Hospital) for their helpful comments on an earlier draft of this paper and to Dr. D Hutchinson for his considerable support with this project. We thank Mr. Andy Barton for his help in setting up the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goh, L., Suresh, P., Gafoor, A. et al. Disease activity in longstanding ankylosing spondylitis—a correlation of clinical and magnetic resonance imaging findings. Clin Rheumatol 27, 449–455 (2008). https://doi.org/10.1007/s10067-007-0726-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0726-7